A study to evaluate the efficacy of a Siddha medicine (Kabasura kudineer) in the treatment of fever in children

A Clinical management of "Kabasuram" with trial drug Kaba sura Kudineer- An open trial in children.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/09/005072

Enrollment

Registered

2014-09-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- kabasuram

Interventions

Intervention1: Kabasura kudineer: Kabasura kudineer polyherbal formulation- 7to 10 years - 15ml [bid] 10 to 12years â?? 30ml [bid].3 days Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: a. Age 7 to 12years b. Children, who are having the symptoms like temperature(99-101F) c. Fever upto 3 days d. Difficulty in breathing Dry or productive cough Head ache, Constipation, Running nose, Malaise, Polyarthralgia. e. Willing to give specimen of blood for investigation when required. f. Willing to attend the OPD on fourth day of treatment.

Exclusion criteria

Exclusion criteria: A patients is not eligible for admission to the trail if any following is applicable temp >101F fever >3days Convulsions, Jaundice, Typhoid, Malaria,Active primary complex,Pneumonia,Rheumatic fever,Urinary tract infection.

Design outcomes

Secondary

Measure	Time frame
â?¢ Moderate prognosis â?¢ Decrease in temperature Timepoint: 7-10 days	—

Primary

Measure	Time frame
â?¢ Good prognosis â?¢ decrease in temperature cough with expectoration difficulty in breathing and other clinical symptoms Timepoint: 7-14 days	—

Countries

India

Contacts

Public ContactDr M Meenakshisundaram

National institute of siddha

cpkarthik1979@gmail.com9788216136

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026